<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
"http://www.w3.org/TR/html4/strict.dtd">
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>
	<!-- CSS
  ================================================== -->
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/layout.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/content.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/print.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/font-awesome.css">	

	<!-- Basic Page Needs
  ================================================== -->
    <script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/jquery-1.8.3.min.js" type="text/javascript"></script>
    <script type="text/x-mathjax-config">
	MathJax.Hub.Config({
	  "HTML-CSS": { linebreaks: { automatic: true } },
	         SVG: { linebreaks: { automatic: true } }
	});
	</script>
    <script type="text/javascript" src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
	<meta charset="utf-8">
	<title>Endocrine &amp; Metabolism</title>
	<meta name="description" content="Course Notes for Endocrine &amp; Metabolism">
	<meta name="author" content="Kevan Lu">
	<meta name="robots" content="noindex,nofollow"/>
	
	<!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0"/>
	
	<script>
	  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
	  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
	  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
	  })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

	  ga('create', 'UA-40381402-3', 'auto');
	  ga('send', 'pageview');
	</script>

	<!-- Favicons
	================================================== -->
	<link rel="shortcut icon" href="https://dl.dropboxusercontent.com/u/157117/Class%20References/favicon.png" type="image/png">

	<!-- iOS Icons
	================================================== -->
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-iphone.png" rel="apple-touch-icon"/>
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-ipad.png" rel="apple-touch-icon" sizes="76x76" />
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-iphone-retina.png" rel="apple-touch-icon" sizes="120x120"/>
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-ipad-retina.png" rel="apple-touch-icon" sizes="152x152" />
</head>
<body>
    <div id="home-overlay">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<div id="header-search-icon"><a id="header-search-button"><i class="fa fa-search"></i></a></div>
</div>
<div id="header-search-bar">
	<form class="search" action="http://www.schulichnotes.com/endocrinology/search.html">
	<div><input type="text" value="Search Endocrine &amp; Metabolism" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	</form>
</div>
<div id="overlay"><h1><a style="border:none;" href="http://www.schulichnotes.com/endocrinology">Endocrine &amp; Metabolism</a></h1></div>
    <div class="sidebar-background"></div>
    <div class="sidebar">
        <!-- Displays a Search Bar-->
<div class="search-wrapper">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<form class="search" action="http://www.schulichnotes.com/endocrinology/search.html">
	<div style="float: left;"><input type="text" value="Search Endocrine &amp; Metabolism" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	<div style="float: left;"><input type="button" id="tipue_search_button" onclick="this.form.submit();"></div>
	<div style="clear: left;"></div>
	</form>
</div>

<div class="course-index">
	<a href="http://www.schulichnotes.com/endocrinology">Endocrine &amp; Metabolism</a>
</div>

        <nav>	
	<li class="week">Week 1</li>
	<ul>
		<li class="day">Monday, October 6</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/06/intro-endocrinology.html">Introduction to Endocrinology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/06/endocrine-physiology-hormone-receptors-feedback-loops.html">Endocrine Physiology, Hormone Receptors & Feedback Loops</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/06/thyroid-physiology.html">Thyroid Physiology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/06/thyroid-pharmacology.html">Thyroid Pharmacology</a></li></ul>
		<li class="day">Tuesday, October 7</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/07/clinical-presentation-evaluation-thyroid-disease.html">Clinical Presentation &amp; Evaluation of Thyroid Disease</a></li></ul>
		<li class="day">Wednesday, October 8</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/08/physiology-pathology-parathyroids.html">Physiology &amp; Pathology of the Parathyroids</a></li></ul>
		<li class="day">Thursday, October 9</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/09/hypercalcemia-hypocalcemia.html">Hypercalcemia &amp; Hypocalcemia</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/09/metabolic-bone-disease.html">Metabolic Bone Disease</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/09/thyroid-parathyroid-focal-cases.html">Thyroid/Parathyroid Focal Cases</a></li></ul>
		<li class="day">Friday, October 10</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/10/discussion-thyroid-calcium-cases.html">Discussion of Thyroid &amp; Calcium Cases</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/10/wrap-up-multidisciplinary-head-neck-surgeons.html">Multidisciplinary with Head &amp; Neck Surgeons</a></li></ul>
	</ul>
	<li class="week">Week 2</li>
	<ul>
		<li class="day">Tuesday, October 14</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/14/physiology-adrenal-glucocorticoids-mineralicorticoids-androgen-receptors.html">Physiology of Adrenal Hormones and Steroid Hormone Receptors</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/14/pharmacology-adrenal-glucocorticoids-mineralicorticoids-androgen-receptors.html">Pharmacology of Adrenal Hormones and Steroid Hormone Receptors</a></li></ul>
		<li class="day">Wednesday, October 15</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/15/adrenal-overproduction.html">Adrenal Overproduction</a></li></ul>
		<li class="day">Thursday, October 16</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/16/adrenal-insufficiency.html">Adrenal Insufficiency</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/16/review-adrenal-testing-imaging.html">Review of Adrenal Testing &amp; Imaging</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/16/sex-determination-differentiation.html">Sex Determination &amp; Differentiation</a></li></ul>
		<li class="day">Friday, October 17</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/17/disorders-sexual-differentiation-ambiguous-genitalia.html">Disorders of Sexual Differentiation &amp; Ambiguous Genitalia</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/17/congenital-adrenal-hyperplasia.html">Congenital Adrenal Hyperplasia</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/17/review-week-1-2-jeopardy.html">Review &ndash; Endocrine Jeopardy! Weeks 1 &amp; 2</a></li></ul>
	</ul>
	<li class="week">Week 3</li>
	<ul>
		<li class="day">Monday, October 20</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/20/pituitary-introduction-feedback-loops.html">Pituitary Introduction &amp; Feedback Loops</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/20/pituitary-overproduction-1.html">Pituitary Overproduction I</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/20/pituitary-overproduction-2.html">Pituitary Overproduction II</a></li></ul>
		<li class="day">Tuesday, October 21</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/21/pituitary-insufficiency.html">Pituitary Hormone Insufficiency</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/21/pituitary-gland-imaging.html">Pituitary Gland Imaging</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/21/adrenal-focus-cases.html">Adrenal Focal Cases</a></li></ul>
		<li class="day">Thursday, October 23</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/23/growth-development-normal-growth-short-stature.html">Growth &amp; Development &ndash; Normal Growth &amp; Short Stature</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/23/physiology-normal-puberty.html">Physiology of Normal Puberty</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/23/abnormalities-pubertal-development.html">Abnormalities of Pubertal Development</a></li></ul>
		<li class="day">Friday, October 24</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/24/glucose-homeostasis-pathophysiology-t1dm.html">Physiology of Glucose Homeostasis &amp; Pathophysiology of T1DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/24/pharmacology-t1dm.html">Pharmacology of T1DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/24/management-t1dm.html">Management of T1DM</a></li></ul>
	</ul>
	<li class="week">Week 4</li>
	<ul>
		<li class="day">Monday, October 27</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/27/acute-complications-t1dm.html">Acute Complications of T1DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/27/introduction-physiology-epidemiology-t2dm.html">Introduction to T2DM &ndash; Physiology &amp; Epidemiology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/27/pharmacology-t2dm.html">Pharmacology of T2DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/27/diabetes-nutrition-doctors.html">Diabetes &amp; Nutrition for Doctors</a></li></ul>
		<li class="day">Tuesday, October 28</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/28/pcos-insulin-resistance-syndromes.html">PCOS &amp; Insulin Resistance Syndromes</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/28/pregnancy-diabetes.html">Pregnancy &amp; Diabetes</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/28/child-health-short-stature-disorders-puberty.html">Child Health Small Groups &ndash; Short Stature &amp; Disorders of Puberty</a></li></ul>
		<li class="day">Wednesday, October 29</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/29/therapy-t2dm.html">Therapy for T2DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/29/prevention-t2dm.html">Prevention of T2DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/29/pediatrics-t2dm.html">T2DM in Pediatrics</a></li></ul>
		<li class="day">Thursday, October 30</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/30/complications-t2dm.html">Complications of T2DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/30/prevention-complications-t2dm.html">Prevention of Complications in T2DM</a></li><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/10/30/t1dm-focal-cases.html">T1DM Focal Cases</a></li></ul>
		<li class="day">Friday, October 31</li>
		<ul></ul>
	</ul>
	<li class="week">Week 5</li>
	<ul>
		<li class="day">Monday, November 3</li>
		<ul></ul>
		<li class="day">Tuesday, November 4</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/endocrinology/2014/11/04/t2dm-focal-cases.html">T2DM Focal Cases</a></li></ul>
		<li class="day">Wednesday, November 5</li>
		<ul></ul>
	</ul>
</nav>
    </div>
    <div class="content-offset">
        <div class="content-background"></div>
        <div class="content">
            <div class="single post">
                <!-- Post Layout -->
                <div class="title"><h1>Physiology &amp; Pathology of the Parathyroids</h1></div>
                <info datetime="2014-10-08">
                    <span class="author"><a href="http://www.schulichnotes.com/about.html#peijunzhao">Pei Jun Zhao</a></span>
                    <span class="date">Wednesday, October 08, 2014</span>
                </info>
                <div class="body"><h2 id="lecture-objectives"><strong>Lecture Objectives</strong></h2>
<ol>
  <li>List physiological processes requiring calcium.</li>
  <li>Outline the major organ systems involved in calcium balance and their roles.</li>
  <li>Describe the function and regulation of parathyroid hormone.</li>
  <li>Describe the biosynthesis of Vitamin D and its role in calcium metabolism.</li>
  <li>Discuss features of calcium imbalance syndromes.</li>
</ol>

<h1 id="parathyroid-gland-physiology">Parathyroid Gland Physiology</h1>
<hr />

<h2 id="anatomy-of-the-parathyroid"><strong>Anatomy of the Parathyroid</strong></h2>

<ul>
  <li>On average, there are <em>4 glands behind the thyroid</em>, each about the size of a grain.</li>
  <li>Comprised of brown/fatty vascularized, encapsulated tissue. 
Average 4 glands behind thyroid, each about size of grain; brown/fatty vascularized tissue, encapsulated  </li>
  <li><em>Key Cells in the Parathyroid</em>:
  <span class="sidenote">An <b>oncocyte</b> is an epithelial cell characterized by an excessive amount of mitochondria, resulting in an abundant acidophilic, granular cytoplasm.</span>
    <ol>
      <li><strong>Chief Cells</strong> → sense Ca<sup>2+</sup> and produce PTH.</li>
      <li><strong>Oxyphil (oncocytic) Cells</strong> → large, eosinophilic (pink), granular cytoplasm; lower activity (but more mitochondria).</li>
    </ol>
  </li>
  <li>Structurally arranged into solid nests of cells separated by fibrous/fatty tissue.</li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/vbted25d.png" /></p>

<h2 id="electrolytes-and-hormones"><strong>Electrolytes and Hormones</strong></h2>

<h3 id="calcium">1. <strong>Calcium</strong></h3>
<ul>
  <li><em>Functions</em>: signal transduction, membrane potential, muscle contraction, co-factor; tightly regulated by PTH receptors (GPCR)  </li>
  <li><em>Distribution</em>: 99% in skeleton, 0.5% protein bound, 0.5% ionic; intake/loss about 1 g/day; low intracelluarly, high extracellularly. </li>
  <li><em>Ionic calcium is active</em>; it’s inactive when bound to proteins.</li>
</ul>

<h3 id="parathyroid-hormone-pth">2. <strong>Parathyroid Hormone (PTH)</strong></h3>
<ul>
  <li>PTH: can be secreted in larger or smaller proteins, but <em>only amino acid 1-34 of the polypeptide are active</em> (clinically used as recombinant PTH → Teriparatide).</li>
  <li>These’s active study on how the C-terminus fragments play a role in specificity and efficacy.</li>
  <li>The PTHR receptor is promiscuous; it shares binding with the PTHrP growth factor (PTH related protein).
    <ul>
      <li>In cancers, with upregulation of PTHrP, you can develop something called a humoral hypercalcemia of malignancy, which we’ll see later.</li>
    </ul>
  </li>
  <li>PTH levels change rapidly to keep Ca<sup>2+</sup> levels in a narrow range → so both calcium (and activated Vitamin D3), are <em>tightly regulated</em>.</li>
  <li><strong>Effects of PTH</strong> 
    <ol>
      <li><em>↑ bone turnover</em> (via ↑ osteoclast activity).</li>
      <li><em>↑ renal Ca re-absorption</em> (at the DCT) → <strong>Ca ↑</strong>.</li>
      <li><em>↑ renal PO4 secretion</em> (at the DCT) → <strong>PO4 ↓</strong>.
        <ul>
          <li>PTH has <i>opposing effects</i> on serum Ca and PO4.</li>
        </ul>
      </li>
      <li><em>↑ 1α-hydroxylase activity</em>, also in the kidney (↑ calcitriol). Increases gut Ca absorption.
        <ul>
          <li>Recall that Vitamin D is first hydroxylated in the liver (25-hydroxylation), and is again hydroxylated in the kidney (1-hydroxylation).</li>
          <li>The end product is <em>calcitriol</em> = activated Vitamin D3, which can bind to receptors in the gut and increase Ca<sup>2+</sup> absorption.</li>
          <li><em>Note</em> → there are no PTH receptors in the gut, only Vitamin D3 receptors, so gut absoprtion is an indirect effect.</li>
        </ul>
      </li>
    </ol>
  </li>
  <li>So in summary, PTH directly increases Ca<sup>2+</sup> absorption from bones, indirectly increases absorption from the gut, and directly reduces losses from the kidney.</li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/zp85_jti.png" /></p>

<h3 id="vitamin-d">3. <strong>Vitamin D</strong></h3>
<ul>
  <li>Steroid hormone (cholesterol based).</li>
  <li>Vitamin D3 (<em>cholecalciferol</em>) can either be absorbed from:
    <ol>
      <li><em>Diet</em> → direct consumption.</li>
      <li><em>Skin</em> → D3 precursors in our skin are converted to cholecalciferol via sunlight (UV).</li>
    </ol>
  </li>
  <li>Ideally, dietary Vitamin D isn’t necessary, but in places without as much sun (like Canada), it may be necessary.</li>
  <li><em>Cholecelciferol</em> is converted to 25-hydroxycholecalciferol (aka. <em>calcifediol</em>) by <em>25-hydroxylase</em> (in the liver).</li>
  <li><em>25-hydroxycholecaliferol</em> is converted to 1-25-dihydroxycholecalciferol (<em>calcifitriol</em>, C3) by <em>1α-hydroxylase</em> (in the kidney).
    <ul>
      <li>Recall that 1α-hydroxylase is what was upregulated by PTH.</li>
    </ul>
  </li>
  <li><em>Vitamin D3</em> increases GI tract Ca<sup>2+</sup>/PO<sub>4</sub> absorption, and bone resorption and mineralization as well.</li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/zp85_jti.png" /></p>

<blockquote>
  <h4 id="calcium-metabolism"><strong>Calcium Metabolism</strong></h4>
  <ol>
    <li><em>Cholecaciferol</em> = <em>Vitamin D3</em> is absorbed from diet or the skin (with UV light).</li>
    <li>It’s converted to <em>calcifediol</em> = <em>25-hydroxycholecalciferol</em> in the liver.</li>
    <li>This is then converted to <em>calcitriol</em> = <em>1-25-dihydroxycholecalciferol</em> in the kidney.</li>
  </ol>
</blockquote>

<h2 id="hyperparathyroidism"><strong>Hyperparathyroidism</strong></h2>
<ul>
  <li><strong>Symptoms</strong>: Recall the phrase <em>‘abdominal groans, mental moans, breaking bones, kidney stones’.</em></li>
  <li><strong>1° Hyperparathyroidism</strong>
    <ul>
      <li><em>Almost always caused by benign adenomas of the parathyroid</em>.</li>
      <li>The next most common cause is idiopathic hyperplasia.</li>
      <li><em>Results in hypercalcemia</em> since the PTH increases absorption.</li>
      <li>Can result in stones, and bone pathologies like osteopenia (precursor to osetoporosis).</li>
    </ul>
  </li>
  <li><strong>2° Hyperparathyroidism</strong>
    <ul>
      <li><em>Almost always caused by kidney pathology</em> (chronic kidney disease, renal failure).</li>
      <li>Can also be due to problems with Vitamin D (resistance or deficiency).</li>
      <li>Here, problems with absorbing Vitamin D, or fully activating it (in the kidney), results in less available calcitriol, reducing gut calcium absorption. Hence, in this case, we have an <em>absence of hypercalcemia</em>.</li>
      <li>As a result of reduced Ca<sup>2+</sup> absorption, the parathyroid tries to increase PTH to compensate, leading to hyperparathroidism.</li>
      <li>Since PTH can still directly resorb bone, you still end up with bone pathologies, such as Osteitis Fibrosa Cystica.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="primary-vs-secondary-hyperparathyroidism"><strong>Primary vs Secondary Hyperparathyroidism</strong></h4>

  <table>
    <thead>
      <tr>
        <th style="text-align: left"> </th>
        <th style="text-align: left">Primary</th>
        <th style="text-align: left">Secondary</th>
      </tr>
    </thead>
    <tbody>
      <tr>
        <td style="text-align: left">Common Cause</td>
        <td style="text-align: left"><em>Parathyroid adenoma</em></td>
        <td style="text-align: left"><em>Kidney pathology</em></td>
      </tr>
      <tr>
        <td style="text-align: left">Pathophysiology</td>
        <td style="text-align: left">Hyperactive Parathyroid Tissue</td>
        <td style="text-align: left">Low activated Vitamin D3</td>
      </tr>
      <tr>
        <td style="text-align: left">Distinguishing Feature</td>
        <td style="text-align: left"><em>Hypercalemia</em></td>
        <td style="text-align: left"><em>NO Hypercalemia</em></td>
      </tr>
    </tbody>
  </table>

  <ul>
    <li><em>Both will result in bone resorption</em> and potential complications.</li>
  </ul>
</blockquote>

<h2 id="hypoparathyroidism"><strong>Hypoparathyroidism</strong></h2>

<ul>
  <li><strong>True hypoparathyroidism is almost always iatrogenic</strong>
    <ul>
      <li>Often seen post-thyroidectomy, since the parathyroid glands are hard to dissociate from the thyroid tissue.</li>
      <li>Can occasionally be due to an autoimmune cause.</li>
      <li>Can rarely be due to congenital agenesis (DiGeorge syndrome).</li>
    </ul>
  </li>
  <li><strong>Symptoms of associated Hypocalcemia</strong>:
    <ul>
      <li>Impaired memory, personality changes.</li>
      <li>Numbness (particularly oral).</li>
      <li>Carpopedal spasm (violent muscle spasm).</li>
      <li>More severely, convulsions and tetanus.</li>
    </ul>
  </li>
</ul>

<h2 id="other-disorders-in-calcium-regulation"><strong>Other Disorders in Calcium Regulation</strong></h2>

<ul>
  <li>As we’ve seen above hyper- or hypo-calcemia isn’t necessarily synonymous with hyperparathyroidism or hypoparathyroidism.</li>
  <li>There are a number of other causes of hyper- or hypo-calcemia, some of which are listed below:</li>
</ul>

<p><span class="sidenote">Both Jansen’s Metaphyseal Chondroplasia and Blomstrand’s Chondrodysplasia are extremely rare. To date, there are only 20 known cases of JMC in the world.</span></p>

<ul>
  <li><strong>Mutations in the PTH Receptor</strong>
    <ul>
      <li><strong>Activating Mutation</strong> → <em>Jansen’s Metaphyseal Chondroplasia</em>, results in dwarfism, presumably due to constant resorption of bone.</li>
      <li><strong>Inactivating Mutation</strong> → <em>Blomstrand’s Chondrodysplasia</em>, results in advanced bone maturation, diffuse ossification, and early death.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="remember"><strong>Remember</strong></h4>
  <ul>
    <li><strong>Jansen’s Metaphyseal Chondroplasia</strong> is caused by an <em>activating mutation</em> in the PTH receptor.</li>
    <li><strong>Blomstrand’s Chondrodysplasia</strong> is caused by an <em>inactivating mutation</em> in the PTH receptor.</li>
  </ul>
</blockquote>

<ul>
  <li><strong>Ca<sup>2+</sup> sensing receptor mutations</strong> 
    <ul>
      <li>Mutations that impair the body’s ability to sense calcium will make the body think that there’s less calcium than there really is.</li>
      <li>Hence, the calcium-PTH curve shifts to the right, and we have hypercalcemia.</li>
      <li>This results in a disease called <em>familial hypocaliuric hypercalcemia (FHH)</em>.</li>
    </ul>
  </li>
  <li><strong>Humoral Hypercalemia of Malignancy (HHM)</strong>
    <ul>
      <li>Pseudohyperparathyroidism due to a carcinoma that produces the cross-reactive PTHrP, which can bind the PTH receptor and induce hypercalcemia.</li>
      <li>Often seen with prostate cancers.</li>
    </ul>
  </li>
  <li><strong>Vitamin D Toxicity</strong>
    <ul>
      <li>Too much activated Vitamin D → too much calcium resorption → hypercalcemia.</li>
    </ul>
  </li>
  <li><strong>Sarcoidosis</strong>
    <ul>
      <li>Granulomas activate Vitamin D.</li>
    </ul>
  </li>
  <li><strong>Milk-alkali (Burnett’s) Syndrome</strong>
    <ul>
      <li>Name derived from patients who would take lots of milk and antacids (alkaline) to control their dyspepsia.</li>
      <li>Results in hypercalcemia and metabolic alkalosis.</li>
    </ul>
  </li>
</ul>

<h1 id="parathyroid-gland-pathology">Parathyroid Gland Pathology</h1>
<hr />

<h2 id="embryology"><strong>Embryology</strong></h2>
<ul>
  <li><em>3<sup>rd</sup> branchial pouch</em>:
    <ul>
      <li>Inferior parathyroids and thymus, and actually descend below the ones that arise from the 4<sup>th</sup> branchial pouch!</li>
      <li>This is a piece of trivia that’s always asked on the wards, so it’s useful to remember.</li>
      <li>Aberrant migration more common.</li>
    </ul>
  </li>
  <li><em>4<sup>th</sup> branchial pouch</em>:
    <ul>
      <li>Superior parathyroids and ultimobranchial body.</li>
      <li>More constant in position.</li>
    </ul>
  </li>
  <li>Parathyroid glands can end up in all sorts of crazy places, which can make it difficult to identify and preserve them during surgery.</li>
</ul>

<h2 id="microscopy"><strong>Microscopy</strong></h2>
<ul>
  <li>Encapsulated and well vascularized.</li>
  <li>All endocrine organs are well vascularized, to have a medium through which they can secrete hormone.</li>
  <li><strong>2 main cell types</strong>:
    <ol>
      <li><em>Chief Cells</em> → the ‘building block’ of the parathyroid tissue, actively secreting parathyroid hormone.</li>
      <li><em>Oncocytic/Oxyphil Cells</em> → non-functional, senescent cells, and stuffed with mitochondria.</li>
    </ol>
  </li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/ntiru0mm.png" /></p>

<h3 id="parathyroid-adenoma"><strong>Parathyroid Adenoma</strong></h3>
<ul>
  <li>Single enlarged gland, with compensatory atrophy of the other glands.</li>
  <li>Benign, F:M = 4:1, usually single gland.</li>
  <li><em>Pathology</em>: clonal proliferation of chief cells, encapsulated, displace normal tissue </li>
  <li><em>Treatment</em>: surgery (excise another ‘normal’ gland as well to verify that the adenoma is atypical).</li>
</ul>

<h3 id="parathyroid-carcinoma"><strong>Parathyroid Carcinoma</strong></h3>
<ul>
  <li><em>Extremely rare</em>.</li>
  <li><em>Epidemiology</em>: uncommon, older individuals, severe hypercalcemia, larger, infiltrative (neck dissection harder).</li>
  <li><em>Pathology</em>: nests of malignant cells separated by fibrous bands; lymphovascular invasion </li>
  <li><em>Treatment</em>: surgery en bloc resection including ipsilateral thyroid, 50% cure, recurrences often seen within 3 years.</li>
</ul>

<h3 id="primary-parathyroid-hyperplasia"><strong>Primary Parathyroid Hyperplasia</strong></h3>
<ul>
  <li><em>Idiopathic cause</em>.</li>
  <li>Second most common cause of hyperparathyroidism, after a benign adenoma.</li>
  <li>Most of them are sporadic (80%).</li>
  <li>Some are familial (20%), and associated with Multiple Endocrine Neoplasia (MEN1, MEN2A).</li>
</ul>

<h1 id="pharmacology-of-calcium-metabolism">Pharmacology of Calcium Metabolism</h1>
<hr />

<ul>
  <li>The <em>normal serum concentration of calcium</em> is <strong>2.25-2.55 mM.</strong>
    <ul>
      <li>You <i>need</i> to know this!</li>
    </ul>
  </li>
  <li>Ca<sup>2+</sup> concentrations are tightly regulated by <em>3 factors</em>, two of which are clinically important:
    <ol>
      <li><strong>Parathyroid Hormone</strong></li>
      <li><strong>Vitamin D</strong> → not really a vitamin; it’s a hormone.</li>
      <li><em>Calcitonin</em> → recall that this is clinically <i>unimportant</i>, and is produced by the parafollicular cells of the thyroid.</li>
    </ol>
  </li>
  <li>PTH directly affects kidney and bone resorption of calcium, and indirectly affects gut absorption via activated Vitamin D.</li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/_5w8yciy.png" /></p>

<blockquote>
  <h4 id="remember-1"><strong>Remember</strong></h4>
  <ul>
    <li>The <em>normal serum concentration of calcium</em> is <strong>2.25-2.55 mM</strong>.</li>
  </ul>
</blockquote>

<h2 id="vitamin-d-1"><strong>Vitamin D</strong></h2>
<ul>
  <li>Some different types of Vitamin D include:
    <ol>
      <li><strong>Vitamin D3</strong> (<em>cholecalciferol</em>) → what’s absorbed from diet or metabolized with UV exposure. With insufficient sun exposure or dietary vitamin D, you can become deficient. The extreme form is rickets.</li>
      <li><strong>Vitamin D2</strong> (<em>ergocalciferol</em>) → derived from plant metabolism of ergosterol. Slightly different, but same biological effects, without the need for UV exposure. Less potent. <i>This is the form added to milk and bread.</i></li>
      <li><strong>25-(OH)D<sub>3</sub></strong> (<em>calcifediol</em>) → the metabolite formed after 25-hydroxylation in the liver. <i>Most potent metabolite for stimulating renal reabsorption of Ca<sup>2+</sup> and PO<sub>4</sub>.</i></li>
      <li><strong>1,25-(OH)<sub>2</sub>D<sub>3</sub></strong> (<em>calcitriol</em>) → activated vitamin D3. </li>
      <li><strong>Dihydrotachysterol</strong> (DHT) → less potent, used in nephrology.</li>
    </ol>
  </li>
  <li>Vitamin D acts through the following mechanisms (much like PTH):
    <ol>
      <li>to facilitate Ca/PO4 absorption by the small intestine,</li>
      <li>to interact with PTH to enhance Ca/PO4 mobilization from bone, and</li>
      <li>to decrease Ca/PO4 excretion by the kidney.</li>
    </ol>
  </li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/7qmwhks3.png" /></p>

<ul>
  <li>Any of the above types of Vitamin D can be used therapeutically.</li>
  <li>The 4 major uses of Vitamin D are:
 	1. <em>Treatment of hypoparathyroidism.</em>
    <ol>
      <li><em>Prevention and treatment of osteoporosis.</em> Increases gut absorption of Calcium.</li>
      <li>Prophylaxis and cure of nutritional rickets.</li>
      <li>Treatment of metabolic rickets and osteomalacia.</li>
    </ol>
  </li>
  <li>Calcitriol tends to be used when a rapid onset it needed.</li>
  <li>D2, D3 and calcifediol are used more generally for vitamin D supplementation.</li>
  <li><strong>Vitamin D toxicity is extremely dangerous with patients on Digoxin</strong>:
    <ul>
      <li>Recall that digoxin inhibits the Na+/K+ pump in cardiomyocytes.</li>
      <li>Without the Na+/K+ pump, sodium accumulates in the cell, and as a response, the cell uses a Na+/Ca++ pump, which causes an accumulation of intracellular calcium. This increases contractility.</li>
      <li><em>With even more plasma calcium, this effect can be dangerously exaggerated.</em></li>
    </ul>
  </li>
</ul>

<h2 id="other-drugs-affecting-calcium-metabolism"><strong>Other Drugs Affecting Calcium Metabolism</strong></h2>

<blockquote>
  <h4 id="treatments-for-osteoporosis"><strong>Treatments for Osteoporosis</strong></h4>

  <table>
    <thead>
      <tr>
        <th style="text-align: left"><em>Inhibitors of Resorption</em></th>
        <th style="text-align: left"><em>Stimulators of Bone Formation</em></th>
      </tr>
    </thead>
    <tbody>
      <tr>
        <td style="text-align: left">Bisphosphonates</td>
        <td style="text-align: left">Sodium fluoride</td>
      </tr>
      <tr>
        <td style="text-align: left">Vitamin D (&amp; Ca<sup>2+</sup>)</td>
        <td style="text-align: left">PTH (teriparatide)</td>
      </tr>
      <tr>
        <td style="text-align: left">Hormone Replacement Therapy (HRT)</td>
        <td style="text-align: left">Strontium ranelate</td>
      </tr>
      <tr>
        <td style="text-align: left">Selective Estrogen Receptor Modifiers (SERMs)</td>
        <td style="text-align: left"> </td>
      </tr>
      <tr>
        <td style="text-align: left">RANK-L Inhibitors</td>
        <td style="text-align: left"> </td>
      </tr>
    </tbody>
  </table>
</blockquote>

<ol>
  <li><strong>Bisphosphonates</strong>
    <ul>
      <li>Incorporates into bone. Inhibits osteoclasts to prevent calcium loss from bone.</li>
      <li><em>___dronate</em> drugs → alendronate, risedronate, pamidronate, etc.</li>
      <li><em>Uses</em>: Osteoporosis, Paget’s Disease. Pamidronate is used more with hypercalcemia. Zolendronate (newer bisphosphonate) is used for malignancy and osteolytic bone lesions.</li>
      <li><em>Adverse effects</em>: headache, rash, abdominal discomfort, MSK/bone pain, diarrhea, loss of taste, <i>gastric irritation</i>, osteonecrosis of jaw (very rare).</li>
    </ul>
  </li>
  <li><strong>Hormone Replacement Therapy</strong>
    <ul>
      <li>Used less often now for osteoporosis since the rise of bisphosphonates, and recent clinical trials.</li>
    </ul>
  </li>
  <li><strong>Selective estrogen receptor modifier (SERM)</strong>
    <ul>
      <li><em>Raloxifene</em> → mediates factors produced by osteoblasts.</li>
    </ul>
  </li>
  <li><strong>RANK-L Inhibitors</strong>
    <ul>
      <li>Receptor activator of nuclear factor κB ligand.</li>
      <li><em>Denosumab (Prolia)</em> → inhibits osteoclast action.</li>
    </ul>
  </li>
  <li><strong>Recombinant PTH</strong>
    <ul>
      <li><em>Teriparatide (Forteo)</em>. Expensive ($$$).</li>
    </ul>
  </li>
  <li><strong>Calcimimetic Drugs</strong>
    <ul>
      <li><em>Cinacalcet (Sensipar)</em> → allosteric activator of Ca sensing receptor on parathyroid chief cells, increasing calcium sensitivity, leading to decreased PTH secretion at the same calcium concentration.</li>
    </ul>
  </li>
  <li><strong>More</strong> 
    <ul>
      <li>Thiazide diuretics reduce Ca excretion.</li>
      <li>Loop diuretics increase Ca excretion.</li>
      <li>Glucocorticoids increase bone resorption.</li>
      <li>Fluoride stimulates bone growth, but only in quantities far above what’s available in our water supply. In excess it can lead to flurosis.</li>
    </ul>
  </li>
</ol>
                
                </div>
            </div>
            <div class="pagination">
                <div style="width:50%; float:left;">
                     
                        <a class="newer" href="http://www.schulichnotes.com/endocrinology/2014/10/07/clinical-presentation-evaluation-thyroid-disease.html"><i class="fa fa-angle-left"></i> Clinical Presentation &amp; Evaluation of Thyroid Disease</a> 
                     
                </div>
                <div style="width:50%; float:right;">
                     
                        <a class="older" href="http://www.schulichnotes.com/endocrinology/2014/10/09/hypercalcemia-hypocalcemia.html">Hypercalcemia &amp; Hypocalcemia <i class="fa fa-angle-right"></i></a> 
                     
                </div>
            </div>
        </div>
    </div>
    <script src="http://www.schulichnotes.com/endocrinology/index.js" type="text/javascript"></script>
<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/search.css">	
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/tipuesearch_set.js" type="text/javascript"></script>
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/tipuesearch.js" type="text/javascript"></script>
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/classie.js" type="text/javascript"></script>
<script>
var search = document.getElementById('header-search-icon');
var searchbar = document.getElementById('header-search-bar');
search.onclick = function(){classie.toggle(searchbar, 'search-bar-open');}
$(document).ready(function() {$('#tipue_search_input').tipuesearch();});
</script>
</body>
</html>